CMS plans to limit the number of nonstandardized Affordable Care Act (ACA) exchange plans offered by each insurer in 2024; CVS and Walgreens agree to settle on lawsuits revolving around their role in the opioid crisis; cases of COVID-19 rise during the holiday season as people meet with their families.
The Biden administration is looking to limit the number of nonstandardized Affordable Care Act (ACA) exchange plans that an insurer can offer to make it easier for enrollees to pick a plan, according to Fierce Healthcare. The proposal would limit the number of exchange plans offered to 2. The proposal also included plans to lower user fees and make changes to network adequacy standards in 2024. CMS had introduced standardized plan options in 2023 for consumers to choose from in small group markets and HealthCare.gov. CMS had previously expressed concern about the increase in plans that consumers could choose from.
A combined $10 billion will be paid by Walgreens and CVS in a lawsuit that sought to hold the companies accountable for the opioid crisis, according to The Associated Press. Finalized settlements over opioids have totaled more than $50 billion in recent years, with this current deal from Walgreens and CVS among the largest. Walmart, another pharmacy operator, had agreed to pay $3.1 billion just last month. Most of this money is set to be used to combat the opioid epidemic, which has been linked to more than 500,000 deaths in the United States within the past 2 decades.
State health officials are urging people to get vaccinated before the Christmas holidays as COVID-19 cases rise across the country, according to Politico. Positive tests for COVID-19 have risen 30% since Thanksgiving, and 30,000 patients are in the hospital. Health experts believe that the surge in COVID-19 may be milder compared with years past but worry about how hospitals will cope with the uptick in cases given staffing shortages and the strain of increasing respiratory syncytial virus and flu cases. Only 13% of Americans over the age of 5 years have received their updated booster vaccine.
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen